Author

Katharina E. Meijboom

University of Massachusetts Chan Medical SchoolORCID 0000-0003-0151-2983Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Assay:CRISPR screen· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Abbas Abdallah· 1 shared Alireza EdrakiiD· 1 shared Aydan KahrimaniD· 1 shared Caleb WebberiD· 1 shared Carolyn KrausiD· 1 shared Christian MuelleriD· 1 shared Erik J. SontheimeriD· 1 shared Fen‐Biao GaoiD· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Abbas Abdallah

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologyNature CommunicationsPeer-reviewedOct 21, 2022

CRISPR/Cas9-Mediated Excision of ALS/FTD-Causing Hexanucleotide Repeat Expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro

Katharina E. Meijboom, Abbas Abdallah, Nicholas P. Fordham…·Christian Mueller

This study removes a hexanucleotide repeat expansion in C9ORF72 using CRISPR/Cas9 in cell and animal models, reducing disease hallmarks.

72 citationstop 2%

𝕏 PostBluesky

NeurosciencebioRxivPreprintDec 17, 2019

Combining multi-omics and drug perturbation profiles to identify novel treatments that improve disease phenotypes in spinal muscular atrophy

Katharina E. Meijboom, Viola Volpato, Jimena Monzón‐Sandoval…·Mélissa Bowerman

This study identifies novel drug treatments for spinal muscular atrophy by integrating multi-omics data and drug perturbation profiles, showing harmine improves disease phenotypes in models.

1 citation

mouseproteomics

𝕏 PostBluesky